| GTO ID | GTC0303 |
| Trial ID | NCT02719782 |
| Disease | Recurrent Hepatocellular Carcinoma |
| Altered gene | X |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | HBV TCR-T cells |
| HLA | HLA class I |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | A Phase I Study T Cell Receptor-Redirected T Cells Infusions in Subjects With Recurrent HBV-Related Hepatocellular Carcinoma in Post Liver Transplantation |
| Year | 2016 |
| Country | China |
| Company sponsor | Lion TCR Pte. Ltd. |
| Other ID(s) | LTCR-HCC-2-1 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||